Researchers are also testing a number of other solutions that may help relieve the symptoms of interstitialcystitis, including hyaluronan, chondroitin sulfate and oxybutynin.
The first application, currently in clinical development, is to treat interstitialcystitis (IC), a painful bladder disease in women that forces them to urinate every 10 minutes.
It plans one for the stent product that it hopes will be approved in 2014 and another for the interstitialcystitis product expected to be approved in 2015.